Biotoxtech Co Ltd

KRX • Healthcare • Diagnostics & Research • Quote as of 10/28/2026 15:30

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeKRX

Market Capitalization32,044 mln

Float11.20 mln

Piotroski F-Score

7 / 9

Strong

Beneish M-Score

-2.93

Likely reliable

Relative Strength

68 / 100

Outperforming

Debt / Equity

1.29

Elevated leverage

Pre-Tax Margin

-11%

Loss-making

ROE

-10.53

Negative

Key Fundamentals

EPS-299

ROE-10.53

ROIC-2.76

ROA-3.04

EBITDA, mln4,153

EV / EBITDA8.95

EV / EBIT-119

Revenue, mln52,476

EV / Revenue0.71

Quote Details

Last 2,110.00

Change 30 (1.44%)

Open 2,080.00

Volume 8,748

Turnover 18,458,280

Average Volume 8,768.67

Financial Ratios

Pre-Tax Profit Margin-11

Current Ratio0.54

Price / Book1.56

Price / Tangible Book1.64

Price / Free Cash Flow16.48

Debt / Equity1.29

Price / Sales0.69

Financial Strength

Altman Z-Score0.11

Piotroski F-Score 7 / 9

Beneish M-Score-2.93

Shiller PE Ratio176

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	3.18%	87 / 100
1 Month	-5.8%	51 / 100
2 Months	1.2%	69 / 100
6 Months	-36.06%	30 / 100
1 Year	-27.74%	32 / 100